[Perioperative chemotherapy in squamous cell carcinomas of the esophagus].
In the majority of patients with esophageal cancer local tumor infiltration and/or distant metastases are responsible for the poor prognosis. Therefore to improve life expectancy additional modalities - chemotherapy alone or in combination with simultaneous radiation - have been introduced perioperatively. In spite of a possible increase of resectability convincing data are lacking which could argue for an uncontrolled introduction of the neoadjuvant approach outside investigational studies.
Abteilung Hämatologie/Onkologie Technischen Universität München.
U
U
Fink
G
G
Ries
J R
JR
Siewert
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D011379:Prognosis
Perioperative Chemotherapie bei Plattenepithelcarcinomen des Oesophagus.